Moderna this week announced positive data from a phase 3 trial of its messenger RNA vaccine against seasonal influenza, which ...

Influenza hemagglutinin subunit vaccines are more effective and offer better cross protection against various influenza virus ...

Purdue University researchers now have developed an innovative, paper-based diagnostic test for rapidly detecting avian ...

Influenza A virus (IAV) infection triggers derepression of host transposable elements (TEs), which have the potential to form double-stranded (ds)RNAs and could enhance innate antiviral immunity.

China's top drug regulator has approved a homegrown flu treatment that acts on a novel protein target, adding to the arsenal of weapons against the infectious disease that kills hundreds of thousands ...

The limited therapeutic options against the influenza virus (flu) and increasing challenges in drug resistance make the search for next-generation agents imperative. In this context, heterotrimeric ...

The nucleoprotein (NP) of influenza A virus (IAV) required for IAV replication is a promising target for new antivirals. We previously identified by in silico screening naproxen being a dual inhibitor ...

H5N1, a highly pathogenic avian influenza (HPAI) virus, has been associated with deadly outbreaks among mammals since 2022 and has been included as one of the priority pathogens by the WHO R&D ...